Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial

Luigi Meneghini, Lawrence Blonde, Jasvinder Gill, Arnaud Dauchy, Andrius Bacevicius, Jodi Strong, Timothy S. Bailey

Research output: Contribution to journal › Article › peer-review